Fidaxomicin

Product NDC
0054-0795
Requested package NDC
0054-0795-07
11-digit product format
000540795
Labeler code
0054
Product ID
0054-0795_77be719d-9937-40ab-a73a-b0db15398280
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Fidaxomicin
Dosage form
TABLET, COATED
Route
ORAL
Labeler
Hikma Pharmceuticals USA Inc.
Application
ANDA219737
Marketing category
ANDA
Marketing start
2026-10-07
Substance
FIDAXOMICIN
Active strength
200 mg/1
Pharmacologic classes
Macrolide Antibacterial [EPC], Macrolides [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219737-001FIDAXOMICINFIDAXOMICIN200MGTABLET / ORALAB2026-10-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A219737-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A219737-001FIDAXOMICIN200MGTABLET / ORALAB2026-10-07d4dbc9d85df4…
2026-10-15 13:18:302026-09A219737-001FIDAXOMICIN200MGTABLET / ORALAB2026-10-07c2088c7a36db…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A219737-001AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A219737-001AB1c2088c7a36db…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Fidaxomicin
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
FIDAXOMICIN200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
Z5N076G8YQInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1111106Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
d773c5ee-9361-49b0-871b-af34f3f936beAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FidaxomicinFIDAXOMICINHikma Pharmceuticals USA Inc.d773c5ee-9361-49b0-871b-af34f3f936be2026-10-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219737
application number: ANDA219737
ndc (package): 0054-0795-07
ndc (product): 0054-0795
ndc11 (package): 00054079507

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0054-0795-070005407950720 TABLET, COATED in 1 BOTTLE (0054-0795-07) 2026-10-07NoNoCurrent